374148167	374148167	CD	B-NP	O
|	|	NN	I-NP	O
FLH	FLH	NN	I-NP	O
|	|	NN	I-NP	O
94481519	94481519	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
060161	060161	CD	B-NP	O
|	|	CC	I-NP	O
5/8/2001	5/8/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
NON-HEALING	NON-HEALING	NNP	I-NP	I-protein
ULCER	ULCER	NNP	I-NP	I-protein
LT.	LT.	NNP	I-NP	I-protein
FOOT	FOOT	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/4/2001	6/4/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/19/2001	1/19/2001	CD	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Gangrenous	Gangrenous	JJ	B-NP	O
left	left	JJ	I-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Kommer	Kommer	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
48	48	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
brittle	brittle	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
and	and	CC	O	O
known	known	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
end	end	NN	B-NP	O
stage	stage	NN	I-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
initially	initially	RB	B-ADVP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
dry	dry	JJ	B-NP	O
gangrene	gangrene	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
aspect	aspect	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
first	first	JJ	I-NP	O
toe	toe	NN	I-NP	O
amputation	amputation	NN	I-NP	O
on	on	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
2001	2001	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
poor	poor	JJ	B-NP	O
healing	healing	NN	I-NP	O
requiring	require	VBG	B-VP	O
debridement	debridement	NN	B-NP	O
twice	twice	RB	B-ADJP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
wound	wound	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
irrigated	irrigate	VBN	I-VP	O
and	and	CC	O	O
closed	close	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Operating	Operating	NNP	I-NP	O
Room	Room	NNP	I-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
2001	2001	CD	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
at	at	IN	B-PP	O
his	his	PRP$	B-NP	O
follow	follow	NN	I-NP	O
up	up	RP	B-PRT	O
visit	visit	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
clinic	clinic	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
wound	wound	NN	I-NP	O
was	be	VBD	B-VP	O
erythematous	erythematous	JJ	B-ADJP	O
and	and	CC	O	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
questionably	questionably	RB	B-ADJP	O
infected	infected	JJ	I-ADJP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
was	be	VBD	B-VP	O
opened	open	VBN	I-VP	O
and	and	CC	O	O
debrided	debride	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
current	current	JJ	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chills	chill	NNS	B-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

Mr.	Mr.	NNP	B-NP	O
Cord	Cord	NNP	I-NP	O
now	now	RB	B-ADVP	O
presents	present	VBZ	B-VP	O
preoperatively	preoperatively	RB	B-ADVP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
operative	operative	JJ	I-NP	O
debridement	debridement	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Insulin-dependent	Insulin-dependent	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

End	End	NN	B-NP	O
stage	stage	NN	I-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
on	on	IN	B-PP	O
Tuesday	Tuesday	NNP	B-NP	O
,	,	,	O	O
Thursday	Thursday	NNP	B-NP	O
and	and	CC	O	O
Saturday	Saturday	NNP	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

ETOH	ETOH	NN	B-NP	O
abuse	abuse	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Tobacco	Tobacco	NNP	B-NP	O
abuse	abuse	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Hepatitis	Hepatitis	NN	B-NP	O
C	C	NN	I-NP	O
virus	virus	NN	I-NP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Enteric	Enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
,	,	,	O	O
325	325	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Atenolol	Atenolol	NN	B-NP	O
,	,	,	O	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
calcium	calcium	NN	B-NP	O
acetate	acetate	NN	I-NP	O
,	,	,	O	O
1334	1334	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Zestril	Zestril	NNP	B-NP	O
,	,	,	O	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Prilosec	Prilosec	NNP	B-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
insulin	insulin	NN	B-NP	O
,	,	,	O	O
70-30	70-30	CD	B-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
q	q	NN	B-NP	O
a.m.	a.m.	RB	B-ADVP	O
,	,	,	O	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
q	q	NN	I-NP	O
p.m.	p.m.	NN	I-NP	O
;	;	:	O	O
Norvasc	Norvasc	NN	B-NP	O
,	,	,	O	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
and	and	CC	O	O
Percocet	Percocet	NNP	B-NP	O
prn	prn	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
stable	stable	JJ	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
thin	thin	JJ	I-NP	O
appearing	appearing	NN	I-NP	O
,	,	,	O	O
middle	middle	JJ	B-NP	O
aged	aged	JJ	I-NP	O
Hispanic	Hispanic	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
was	be	VBD	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
III/VI	III/VI	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
neck	neck	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
non-tender	non-tender	JJ	I-NP	O
,	,	,	I-NP	O
non-distended	non-distended	JJ	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
pulse	pulse	NN	I-NP	O
examination	examination	NN	I-NP	O
showed	show	VBD	B-VP	O
palpable	palpable	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
and	and	CC	O	O
dopplerable	dopplerable	JJ	B-NP	O
DP	DP	NN	I-NP	O
,	,	,	O	O
PT	PT	NN	B-NP	O
and	and	CC	O	O
peroneal	peroneal	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
open	open	JJ	I-NP	O
wound	wound	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
purulent	purulent	JJ	I-NP	O
discharge	discharge	NN	I-NP	O
and	and	CC	O	O
minimal	minimal	JJ	B-NP	O
erythema	erythema	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
surrounding	surround	VBG	I-NP	O
skin	skin	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABORATORY	LABORATORY	NN	I-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
136	136	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.9	4.9	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
96	96	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
36	36	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
17	17	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
3.8	3.8	CD	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
glucose	glucose	NN	I-NP	O
of	of	IN	B-PP	O
469	469	CD	B-NP	O
.	.	.	O	O

CBC	CBC	NN	B-NP	B-protein
-	-	HYPH	O	O
9.4	9.4	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
30.3	30.3	CD	I-NP	I-protein
and	and	CC	O	O
platelet	platelet	NN	B-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
460	460	CD	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
of	of	IN	B-PP	O
1.2	1.2	CD	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
angiogram	angiogram	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
common	common	JJ	I-NP	O
iliac	iliac	JJ	I-NP	O
artery	artery	NN	I-NP	O
had	have	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
external	external	JJ	I-NP	O
iliac	iliac	JJ	I-NP	O
artery	artery	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
left	left	JJ	I-NP	O
SFA	SFA	NNP	I-NP	O
had	have	VBD	B-VP	O
proximal	proximal	JJ	B-NP	O
50	50	CD	I-NP	O
to	to	TO	I-NP	O
60	60	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
and	and	CC	O	O
mid-50	mid-50	CD	B-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
popliteal	popliteal	NN	I-NP	O
had	have	VBD	B-VP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
tibial	tibial	JJ	I-NP	O
peroneal	peroneal	JJ	I-NP	O
trunk	trunk	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
had	have	VBD	B-VP	O
moderate	moderate	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Vascular	Vascular	NNP	I-NP	O
Service	Service	NNP	I-NP	O
and	and	CC	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
Vancomycin	Vancomycin	NN	B-NP	O
,	,	,	I-NP	O
Levofloxacin	Levofloxacin	NN	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
wound	wound	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
prepared	prepare	VBN	I-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
operative	operative	JJ	I-NP	O
debridement	debridement	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
pulses	pulse	NNS	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
dopplerable	dopplerable	JJ	B-ADJP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
very	very	RB	B-ADJP	O
difficult	difficult	JJ	I-ADJP	O
to	to	TO	B-PP	O
control	control	NN	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
being	be	VBG	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
sugars	sugar	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
400	400	CD	I-NP	O
to	to	TO	I-NP	O
500	500	CD	I-NP	O
range	range	NN	I-NP	O
,	,	,	O	O
requiring	require	VBG	B-VP	O
IV	IV	CD	B-NP	O
insulin	insulin	NN	I-NP	O
boluses	bolus	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Operating	Operating	NNP	I-NP	O
Room	Room	NNP	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
debridement	debridement	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
amputation	amputation	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
amputation	amputation	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
second	second	JJ	I-NP	O
toe	toe	NN	I-NP	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
closure	closure	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
under	under	IN	B-PP	O
ankle	ankle	NN	B-NP	O
block	block	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
uncomplicated	uncomplicated	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
postoperative	postoperative	JJ	I-NP	O
course	course	NN	I-NP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
very	very	RB	I-NP	O
difficult	difficult	JJ	I-NP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
diabetes	diabete	NNS	B-NP	O
with	with	IN	B-PP	O
intermittent	intermittent	JJ	B-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
40s	40	NNS	I-NP	O
and	and	CC	I-NP	O
hyperglycemia	hyperglycemia	NN	I-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
600s	600	NNS	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
receive	receive	VB	I-VP	O
a	a	DT	B-NP	O
consult	consult	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
diabetes	diabetes	NN	I-NP	O
team	team	NN	I-NP	O
who	who	WP	B-NP	O
changed	change	VBD	B-VP	O
his	his	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
to	to	TO	B-PP	O
70-30	70-30	CD	B-NP	O
insulin	insulin	NN	I-NP	O
,	,	,	O	O
22	22	CD	B-NP	O
units	unit	NNS	I-NP	O
q	q	NN	I-NP	O
a.m.	a.m.	RB	B-ADVP	O
,	,	,	O	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
at	at	IN	B-PP	O
10	10	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
and	and	CC	O	O
four	four	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
q	q	NN	I-NP	O
p.m.	p.m.	RB	B-ADVP	O
,	,	,	O	O
one-half	one-half	JJ	B-NP	O
hour	hour	NN	I-NP	O
before	before	IN	B-PP	O
his	his	PRP$	B-NP	O
supper	supper	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
covered	cover	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
receive	receive	VB	I-VP	O
Vancomycin	Vancomycin	NNP	B-NP	O
,	,	,	I-NP	O
Levofloxacin	Levofloxacin	NNP	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NNP	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
ten	ten	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
8.0	8.0	CD	I-NP	O
to	to	TO	I-NP	O
9.0	9.0	CD	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

Mr.	Mr.	NNP	B-NP	O
Devore	Devore	NNP	I-NP	O
received	receive	VBD	B-VP	O
his	his	PRP$	B-NP	O
dialysis	dialysis	NN	I-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
his	his	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
schedule	schedule	NN	I-NP	O
of	of	IN	B-PP	O
Tuesday	Tuesday	NNP	B-NP	O
,	,	,	O	O
Thursday	Thursday	NNP	B-NP	O
and	and	CC	O	O
Saturday	Saturday	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
intermittent	intermittent	JJ	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
C.	C.	NNP	B-NP	O
diff	diff	NN	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
cultures	culture	NNS	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
are	be	VBP	B-VP	O
still	still	RB	I-VP	O
pending	pende	VBG	I-VP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
fecal	fecal	JJ	I-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
stool	stool	NN	I-NP	O
sample	sample	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
5	5	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
10	10	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
to	to	TO	B-PP	O
11	11	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
range	range	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
7	7	CD	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
slight	slight	JJ	I-NP	O
,	,	,	I-NP	O
questionably	questionably	RB	I-NP	O
purulent	purulent	JJ	I-NP	O
drainage	drainage	NN	I-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
incision	incision	NN	I-NP	O
line	line	NN	I-NP	O
,	,	,	O	O
thus	thus	RB	B-ADVP	O
a	a	DT	B-NP	O
couple	couple	NN	I-NP	O
of	of	IN	B-PP	O
sutures	suture	NNS	B-NP	O
were	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
wound	wound	NN	I-NP	O
was	be	VBD	B-VP	O
opened	open	VBN	I-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
fluid	fluid	NN	I-NP	O
collection	collection	NN	I-NP	O
or	or	CC	I-NP	O
pus	pus	NN	I-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
deep	deep	JJ	I-NP	O
wound	wound	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
wound	wound	NN	I-NP	O
was	be	VBD	B-VP	O
dressed	dress	VBN	I-VP	O
with	with	IN	B-PP	O
wet	wet	JJ	B-ADJP	O
to	to	TO	B-PP	O
dry	dry	JJ	B-NP	O
dressing	dressing	NN	I-NP	O
changes	change	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-VP	O
using	use	VBG	I-VP	O
normal	normal	JJ	B-NP	O
saline	saline	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
directed	direct	VBN	I-VP	O
specifically	specifically	RB	B-ADVP	O
to	to	TO	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
packed	pack	VBN	I-VP	O
tightly	tightly	RB	B-ADVP	O
but	but	CC	I-ADVP	O
just	just	RB	I-ADVP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
wicked	wicke	VBN	I-VP	O
open	open	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
were	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
Augmentin	Augmentin	NN	B-NP	O
and	and	CC	I-NP	O
Levofloxacin	Levofloxacin	NN	I-NP	O
impirically	impirically	RB	B-ADVP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cultures	culture	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
drainage	drainage	NN	I-NP	O
from	from	IN	B-PP	O
negative	negative	JJ	B-NP	O
as	as	IN	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Flagyl	Flagyl	NN	B-NP	O
for	for	IN	B-PP	O
impiric	impiric	JJ	B-NP	O
coverage	coverage	NN	I-NP	O
of	of	IN	B-PP	O
C.	C.	NNP	B-NP	O
diff	diff	NNP	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
case	case	NN	O	O
his	his	PRP$	B-NP	O
C.	C.	NNP	I-NP	O
diff	diff	NN	I-NP	O
toxin	toxin	NN	I-NP	O
turns	turn	VBZ	B-VP	O
out	out	RP	B-PRT	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
for	for	IN	B-PP	O
another	another	DT	B-NP	O
six	six	CD	I-NP	O
days	day	NNS	I-NP	O
post-discharge	post-discharge	JJ	B-ADJP	O
and	and	CC	O	O
this	this	DT	B-NP	O
will	will	MD	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
2.5	2.5	CD	I-NP	O
week	week	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
for	for	IN	B-PP	O
him	him	PRP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
issues	issue	NNS	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
sugars	sugar	NNS	I-NP	O
did	do	VBD	B-VP	O
trough	trough	NN	B-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
9	9	CD	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
of	of	IN	B-PP	O
46	46	CD	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
reconsulted	reconsulte	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
diabetes	diabetes	NN	I-NP	O
team	team	NN	I-NP	O
with	with	IN	B-PP	O
recommendations	recommendation	NNS	B-NP	O
to	to	TO	B-VP	O
decrease	decrease	VB	I-VP	O
his	his	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
;	;	:	O	O
70-30	70-30	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
to	to	TO	B-PP	O
18	18	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
instead	instead	RB	B-PP	O
of	of	IN	I-PP	O
22	22	CD	B-NP	O
units	unit	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
his	his	PRP$	B-NP	O
NPH	NPH	NN	I-NP	B-protein
and	and	CC	I-NP	O
regular	regular	JJ	I-NP	O
insulin	insulin	NN	I-NP	O
coverage	coverage	NN	I-NP	O
as	as	IN	B-SBAR	O
previously	previously	RB	B-ADVP	O
recommended	recommend	VBN	B-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
stable	stable	JJ	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Heart	Heart	NNP	B-NP	O
is	be	VBZ	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
is	be	VBZ	B-VP	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
non-tender	non-tender	JJ	I-NP	O
,	,	,	I-NP	O
non-distended	non-distended	JJ	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
pulses	pulse	NNS	I-NP	O
are	be	VBP	B-VP	O
still	still	RB	B-ADVP	O
dopplerable	dopplerable	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
wound	wound	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
erythema	erythema	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
packed	pack	VBN	I-VP	O
open	open	RP	B-PRT	O
with	with	IN	B-PP	O
clean	clean	JJ	B-NP	O
granulation	granulation	NN	I-NP	O
tissue	tissue	NN	I-NP	O
and	and	CC	O	O
some	some	DT	B-NP	O
slight	slight	JJ	I-NP	O
fibrinous	fibrinous	JJ	I-NP	O
exudate	exudate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
distal	distal	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Vitamin	Vitamin	NN	B-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
250	250	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Enteric	Enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
,	,	,	O	O
325	325	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Atenolol	Atenolol	NN	B-NP	O
,	,	,	O	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Calcium	Calcium	NN	B-NP	O
acetate	acetate	NN	I-NP	O
,	,	,	O	O
1334	1334	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Folate	Folate	NNP	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Heparin	Heparin	NN	B-NP	O
,	,	,	O	O
subcutaneously	subcutaneously	RB	B-ADVP	O
,	,	,	O	O
5000	5000	CD	B-NP	O
units	unit	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
;	;	:	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Zestril	Zestril	NNP	B-NP	O
,	,	,	O	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
h.s.	h.s.	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Flagyl	Flagyl	NN	B-NP	O
,	,	,	O	O
p.o.	p.o.	FW	B-NP	O
,	,	,	O	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
six	six	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Prilosec	Prilosec	NNP	B-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Thiamine	Thiamine	NN	B-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Zinc	Zinc	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
,	,	,	O	O
220	220	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Simvastatin	Simvastatin	NN	B-NP	O
,	,	,	O	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
h.s.	h.s.	NN	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

Norvasc	Norvasc	RB	B-ADVP	O
,	,	,	O	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Nephrocaps	Nephrocaps	RB	B-ADVP	O
,	,	,	O	O
1	1	CD	B-NP	O
capsule	capsule	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
,	,	,	O	O
70-30	70-30	CD	B-NP	O
,	,	,	I-NP	O
18	18	CD	I-NP	O
units	unit	NNS	I-NP	O
q	q	NN	I-NP	O
a.m.	a.m.	RB	B-NP	O
subq	subq	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
,	,	,	O	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
q	q	NN	B-NP	O
10	10	CD	I-NP	O
p.m.	p.m.	NN	I-NP	O
subq	subq	NN	I-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subq	subq	NN	I-NP	O
q	q	NN	I-NP	O
p.m.	p.m.	RB	B-ADVP	O
,	,	,	O	O
half	half	JJ	B-NP	O
hour	hour	NN	I-NP	O
before	before	IN	B-PP	O
supper	supper	NN	B-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Augmentin	Augmentin	NNP	B-NP	O
,	,	,	O	O
500/125	500/125	CD	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
x	x	SYM	O	O
6	6	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Levofloxacin	Levofloxacin	NN	B-NP	O
,	,	,	O	O
250	250	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.o.d.	q.o.d.	NN	I-NP	O
x	x	SYM	B-VP	O
three	three	CD	B-NP	O
more	more	JJR	I-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Percocet	Percocet	NNP	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
2	2	CD	I-NP	O
tabs	tab	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
h	h	NN	I-NP	O
prn	prn	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

ACTIVITY	ACTIVITY	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
restricted	restricted	JJ	B-ADJP	O
to	to	TO	B-PP	O
left	left	JJ	B-NP	O
heel	heel	NN	I-NP	O
touch	touch	NN	I-NP	O
only	only	RB	B-ADVP	O
,	,	,	O	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
a	a	DT	B-NP	O
walker	walker	NN	I-NP	O
for	for	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
assistance	assistance	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
to	to	TO	B-VP	O
put	put	VB	I-VP	O
any	any	DT	B-NP	O
pressure	pressure	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
amputation	amputation	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

PLAN	PLAN	NN	B-NP	O
FOR	FOR	NN	I-NP	O
FOLLOWUP	FOLLOWUP	NN	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Lester	Lester	NNP	I-NP	O
Hirschberg	Hirschberg	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
dialysis	dialysis	NN	I-NP	O
on	on	IN	B-PP	O
Tuesday	Tuesday	NNP	B-NP	O
,	,	,	O	O
Thursday	Thursday	NNP	B-NP	O
and	and	CC	O	O
Saturday	Saturday	NNP	B-NP	O
per	per	IN	B-PP	O
his	his	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
schedule	schedule	NN	I-NP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
for	for	IN	B-PP	O
optimization	optimization	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
glycemic	glycemic	JJ	I-NP	O
control	control	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
FABIAN	FABIAN	NNP	B-NP	O
STIDMAN	STIDMAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
WD064	WD064	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TERENCE	TERENCE	NNP	B-NP	O
RUSSLER	RUSSLER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
WH80	WH80	NNP	I-NP	O
QB463/518353	QB463/518353	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
8449	8449	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

WODVQR842E	WODVQR842E	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
10/29/01	10/29/01	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/29/01	10/29/01	CD	B-NP	O

